DIR-visible grey matter lesions and atrophy in multiple sclerosis: Partners in crime?

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 87, Issue 5, 2016, Pages 461-467

  Van De Pavert, Steven H P ^a   Muhlert, Nils ^a,b   Sethi, Varun ^a   Wheeler Kingshott, Claudia A M ^a   Ridgway, Gerard R ^a,c   Geurts, Jeroen J G ^d   Ron, Maria ^a   Yousry, Tarek A ^a   Thompson, Alan J ^a,e   Miller, David H ^a,e   Chard, Declan T ^a,e   Ciccarelli, Olga ^a,e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN MAPPING; BRAIN REGION; BRAIN SIZE; BRAIN TISSUE; CAUDATE NUCLEUS; CEREBELLUM; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DOUBLE INVERSION RECOVERY MAGNETIC RESONANCE IMAGING; EXECUTIVE FUNCTION; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; GRAY MATTER ATROPHY; GRAY MATTER LESION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MENTAL PERFORMANCE; MOTOR DYSFUNCTION; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL DISABILITY; POSTCENTRAL GYRUS; PRIORITY JOURNAL; PUTAMEN; THALAMUS; TISSUE DISTRIBUTION; VOXEL BASED MORPHOMETRY; ATROPHY; BRAIN; CASE CONTROL STUDY; COMPLICATION; MIDDLE AGED; NEUROIMAGING; PATHOLOGY;

ADULT; ATROPHY; BRAIN; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; GRAY MATTER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; NEUROIMAGING;

EID: 84930399740     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-310142     Document Type: Article

References (41)

1. Geurts JJG, Calabrese M, Fisher E, et al. Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol 2012;11:1082-92.
2. Bø L, Vedeler CA, Nyland HI, et al. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003;62:723-32. http://www.ncbi.nlm.nih.gov/pubmed/12901699 (accessed 30 May 2013).
3. Geurts JJG, Bø L, Pouwels PJW, et al. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005;26:572-7. http://www.ajnr.org/content/26/3/572.short(accessed 13 Feb 2013).
4. Seewann A, Kooi EJ, Roosendaal SD, et al. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012;78:302-8.
5. Calabrese M, Battaglini M, Giorgio A, et al. Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis. Neurology 2010;75:1234-40.
6. Calabrese M, Rocca MA, Atzori M, et al. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol 2010;67:376-83.
7. Sepulcre J, Goñi J, Masdeu JC, et al. Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway. Arch Neurol 2009;66:173-9.
8. Mühlau M, Buck D, Förschler A, et al. White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI. Mult Scler 2013;19:1485-92.
9. Wegner C, Esiri MM, Chance SA, et al. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006;67:960-7.
10. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
11. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52. http://www.ncbi.nlm.nih.gov/pubmed/6685237(accessed 22 May 2013).
12. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70. http://www.ncbi.nlm.nih.gov/pubmed/6880820(accessed 11 Jul 2014).
13. Burgess P, Shallice T. The Hayling and Brixton tests. Test manual. Bury St Edmunds, UK: Thames Valley Test Company, 1997.
14. Trennery MR. Stroop neuropsychological screening test manual. Odessa, FL: Psychological Assessment Resources, 1989.
15. Smith A. Symbol digit modalities test (SDMT): manual (revised). Los Angeles: Western Psychological Services, 1982.
16. Coughlan A, Hollows S. The adult memory and information processing battery (AMIPB). Leeds, UK: St James University Hospital, 1985.
17. Warrington EK. Manual for recognition memory test. Windsor, UK: NFER-Nelson, 1984.
18. Chard DT, Jackson JS, Miller DH, et al. Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J Magn Reson Imaging 2010;32:223-8.
19. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007;38:95-113.
20. Mallik S, Muhlert N, Samson RS, et al. Regional patterns of grey matter atrophy and magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups: a voxel-based analysis study. Mult Scler 2015;21:423-32.
21. Geurts JJG, Roosendaal SD, Calabrese M, et al. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 2011;76:418-24.
22. Winkler AM, Ridgway GR, Webster MA, et al. Permutation inference for the general linear model. Neuroimage 2014;92:381-97.
23. Casanova R, Srikanth R, Baer A, et al. Biological parametric mapping: a statistical toolbox for multimodality brain image analysis. Neuroimage 2007;34:137-43.
24. Genova HM, Hillary FG, Wylie G, et al. Examination of processing speed deficits in multiple sclerosis using functional magnetic resonance imaging. J Int Neuropsychol Soc 2009;15:383-93.
25. Cardinal KS, Wilson SM, Giesser BS, et al. A longitudinal fMRI study of the paced auditory serial addition task. Mult Scler 2008;14:465-71.
26. Fischl B, Salat DH, Busa E, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341-55.http://www.ncbi.nlm.nih.gov/pubmed/11832223 (accessed 22 May 2013).
27. Desikan RS, Ségonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006;31:968-80.
28. Ceccarelli A, Rocca MA, Pagani E, et al. A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. Neuroimage 2008;42:315-22.
29. Audoin B, Davies GR, Finisku L, et al. Localization of grey matter atrophy in early RRMS: a longitudinal study. J Neurol 2006;253:1495-501.
30. Morgen K, Sammer G, Courtney SM, et al. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS. Neuroimage 2006;30:891-8.
31. Sailer M, Fischl B, Salat DH, et al. Focal thinning of the cerebral cortex in multiple sclerosis. Brain 2003;126:1734-44.
32. Calabrese M, Atzori M, Bernardi V, et al. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 2007;254:1212-20.
33. Sepulcre J, Sastre-Garriga J, Cercignani M, et al. Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. Arch Neurol 2006;63:1175-80.
34. Ceccarelli A, Rocca MA, Falini A, et al. Normal-appearing white and grey matter damage in MS. A volumetric and diffusion tensor MRI study at 3.0 Tesla. J Neurol 2007;254:513-18.
35. Armitage P, Berry G, Matthews J. Statistical methods in medical research. 4th ed. Blackwell Science Ltd, 2002.
36. Stoodley CJ, Valera EM, Schmahmann JD. Functional topography of the cerebellum for motor and cognitive tasks: an fMRI study. Neuroimage 2012;59:1560-70.
37. Muhlert N, Atzori M, De Vita E, et al. Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions. J Neurol Neurosurg Psychiatry 2014;85:833-9.
38. Muhlert N, Sethi V, Cipolotti L, et al. The grey matter correlates of impaired decision-making in multiple sclerosis. J Neurol Neurosurg Psychiatry 2014;86:530-6.
39. Haider L, Simeonidou C, Steinberger G, et al. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron. J Neurol Neurosurg Psychiatry 2014;85:1386-95.
40. Sethi V, Yousry TA, Muhlert N, et al. Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J Neurol Neurosurg Psychiatry 2012;83:877-82.
41. Oken BS, Flegal K, Zajdel D, et al. Cognition and fatigue in multiple sclerosis: potential effects of medications with central nervous system activity. J Rehabil Res Dev 2006;43:83-90. http://www.ncbi.nlm.nih.gov/pubmed/16847774(accessed 19 Mar 2015).